Results 81 to 90 of about 1,884 (153)

Efficacy and Predictors of Response to Biologic Therapy and Endoscopic Sinus Surgery in Patients With Nasal Polyps: A Systematic Review

open access: yesInternational Forum of Allergy &Rhinology, Volume 16, Issue 11, Page 1342-1351, November 2026.
ABSTRACT Background Biologics and endoscopic sinus surgery (ESS) treat refractory chronic rhinosinusitis with nasal polyposis (CRSwNP), but direct comparisons are lacking. We synthesized efficacy and subgroup data across randomized controlled trials (RCTs) of biologics and ESS.
Arun Chakravorty   +13 more
wiley   +1 more source

Pharmacokinetics of indacaterol acetate and mometasone furoate delivered alone or in a free or fixed dose combination in healthy volunteers

open access: yes, 2016
Purpose: QMF149 is a fixed-dose combination of the long-acting β2 agonist, indacaterol acetate and the corticosteroid, mometasone furoate that is currently under development for treatment of patients with asthma and chronic obstructive pulmonary disease.
Calder, Nicole   +7 more
core   +1 more source

Response to a combination therapy of cemiplimab and cetuximab in cutaneous squamous cell carcinoma – a case report

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Katja Schabet   +3 more
wiley   +1 more source

A comparison of mometasone versus triamcinolone-soaked gelfoam in reducing postoperative inflammation and adhesions after functional endoscopic sinus surgery: a randomized controlled trial

open access: yesThe Egyptian Journal of Otolaryngology
Background Intranasal corticosteroids are widely used following functional endoscopic sinus surgery (FESS) to reduce inflammation and prevent postoperative complications.
Mohamed Mahmoud ElSheikh   +3 more
doaj   +1 more source

Therapy with lebrikizumab for refractory peristomal irritant contact dermatitis

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Olivia Danneil   +2 more
wiley   +1 more source

Nemolizumab for Pruritus Control in Cutaneous T‐Cell Lymphoma: A Case Series

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Yenny Angela   +2 more
wiley   +1 more source

Bioequivalence of 0.1% mometasone furoate lotion to 0.1% mometasone furoate hydrogel

open access: yesAustralasian Journal of Dermatology, 2014
AbstractBackground/ObjectivesVehicles used for topical therapy can affect drug delivery and patient adherence. This study compared the bioequivalence of 0.1% mometasone furoate lotion (reference) and 0.1% mometasone furoate hydrogel (test). Moisturising capacity and sensitivity/irritancy potential were also determined.MethodsBioequivalence was assessed
Kerryn A, Greive, Tanya M, Barnes
openaire   +2 more sources

A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis

open access: yes, 2006
Objective: To evaluate the efficacy and safety of mometasone furoate nasal spray (NS) for the treatment of nasal polyposis. Design: Randomized, double-blind, placebo-controlled, pararlel-group, multicenter study.
Stjärne, Pär   +6 more
core   +1 more source

Evaluation of Echinacea Leaf Extract and Allantoin Based Topical Formulations in an Imiquimod-Induced Psoriasis-like Model

open access: yesMedical Sciences
Background/Objectives: Psoriasis is a chronic inflammatory disorder characterized by epidermal hyperproliferation and immune dysregulation. This study evaluated the topical efficacy of Echinacea leaf extract and allantoin compared to a corticosteroid ...
Cristina Burlou-Nagy (Fati)   +9 more
doaj   +1 more source

Use of Mometasone Furoate Aqueous Nasal Spray in the Treatment of Rhinitis Medicamentosa: An Experimental Study

open access: yes, 2005
OBJECTIVE: We aimed to investigate, histopathologic changes in the nasal mucosa of guinea pig's after prolonged administration of oxymetazoline and the development of rhinitis medicamentosa, and the efficacy of mometasone furoate aqueous nasal spray and ...
Tas, A   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy